Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation

Radiology

Volumn 258, Issue 3, 2011, Pages 660-671

  Mahgerefteh, Shmuel Y ^a   Sosna, Jacob ^a,b   Bogot, Naama ^a   Shapira, Michael Y ^a   Pappo, Orit ^a   Bloom, Allan I ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ABDOMINAL RADIOGRAPHY; ACUTE GRAFT VERSUS HOST DISEASE; ADJUVANT THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; INTERVENTIONAL RADIOLOGY; LIVER BIOPSY; LIVER DISEASE; LIVER VENOOCCLUSIVE DISEASE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

DIAGNOSTIC IMAGING; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; RADIOGRAPHY, ABDOMINAL; RADIOGRAPHY, INTERVENTIONAL; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79952295486     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10100025     Document Type: Review

References (98)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006;354(17):1813-1826.
2. Fassas AB, Morris C, Badros A, Van Rhee F, Tricot G. Separating graft-versus-tumor from graft-versus-host reactions. Leuk Lymphoma 2002;43(4):725-733. (Pubitemid 34428659)
3. Jacobsohn DA, Vogelsang GB. Acute graft versus host disease. Orphanet J Rare Dis 2007;2:35.
4. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003;9(4):215-233. (Pubitemid 40045609)
5. Kumar S, DeLeve LD, Kamath PS, Tefferi A. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 2003;78(5):589-598. (Pubitemid 36529900)
6. Przepiorka D, Weisdorf D, Martin P, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15(6):825-828.
7. McDonald GB, Hinds MS, Fisher LD, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993;118(4):255-267. (Pubitemid 23046384)
8. Lee JH, Lim GY, Im SA, Chung NG, Hahn ST. Gastrointestinal complications following hematopoietic stem cell transplantation in children. Korean J Radiol 2008;9(5):449-457.
9. Taylor AJ, Dodds WJ, Gonyo JE, Komorowski RA. Typhlitis in adults. Gastrointest Radiol 1985;10(4):363-369. (Pubitemid 15015064)
10. Kirkpatrick ID, Greenberg HM. Gastrointestinal complications in the neutropenic patient: characterization and differentiation with abdominal CT. Radiology 2003;226(3):668-674. (Pubitemid 36259140)
11. Coy DL, Ormazabal A, Godwin JD, Lalani T. Imaging evaluation of pulmonary and abdominal complications following hematopoietic stem cell transplantation. RadioGraphics 2005;25(2):305-317; discussion 318.
12. Irani JL, Cutler CS, Whang EE, et al. Severe acute gastrointestinal graft-vs-host disease: an emerging surgical dilemma in contemporary cancer care. Arch Surg 2008;143(11):1041-1045; discussion 1046.
13. Schmit M, Bethge W, Beck R, Faul C, Claussen CD, Horger M. CT of gastrointestinal complications associated with hematopoietic stem cell transplantation. AJR Am J Roentgenol 2008;190(3):712-719. (Pubitemid 351304516)
14. Price AB. Pathology of drug-associated gastrointestinal disease. Br J Clin Pharmacol 2003;56(5):477-482. (Pubitemid 37386499)
15. Ash L, Baker ME, O'Malley CM Jr, Gordon SM, Delaney CP, Obuchowski NA. Colonic abnormalities on CT in adult hospitalized patients with clostridium difficile colitis: prevalence and significance of findings. AJR Am J Roentgenol 2006;186(5):1393-1400. (Pubitemid 46112578)
16. Downey DB, Wilson SR. Pseudomembranous colitis: sonographic features. Radiology 1991;180(1):61-64.
17. Frisoli JK, Desser TS, Jeffrey RB. American Roentgen Ray Society. 2000 ARRS Executive Council Award. Thickened submucosal layer: a sonographic sign of acute gastrointestinal abnormality representing submucosal edema or hemorrhage. AJR Am J Roentgenol 2000;175(6):1595-1599.
18. Schmidt ML, Gilligan PH. Clostridium difficile testing algorithms: what is practical and feasible? Anaerobe 2009;15(6):270-273.
19. Colina F, Jucá NT, Moreno E, et al. Histological diagnosis of cytomegalovirus hepatitis in liver allografts. J Clin Pathol 1995;48(4):351-357.
20. He JD, Liu YL, Wang ZF, Liu DH, Chen H, Chen YH. Colonoscopy in the diagnosis of intestinal graft versus host disease and cytomegalovirus enteritis following allogeneic haematopoietic stem cell transplantation. Chin Med J (Engl) 2008;121(14):1285-1289.
21. Kraus MD, Feran-Doza M, Garcia-Moliner ML, Antin J, Odze RD. Cytomegalovirus infection in the colon of bone marrow transplantation patients. Mod Pathol 1998;11(1):29-36. (Pubitemid 28177361)
22. Arai S, Lee LA, Vogelsang GB. A systematic approach to hepatic complications in hematopoietic stem cell transplantation. J Hematother Stem Cell Res 2002;11(2):215-229. (Pubitemid 34309517)
23. Spencer SP, Power N. The acute abdomen in the immune compromised host. Cancer Imaging 2008;8:93-101. (Pubitemid 351722438)
24. Soyer P, Martin-Grivaud S, Boudiaf M, et al. Linear or bubbly: a pictorial review of CT features of intestinal pneumatosis in adults [in French]. J Radiol 2008;89(12):1907-1920.
25. Narimatsu H, Kami M, Hara S, et al. Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation. Bone Marrow Transplant 2005;36(6):517-523. (Pubitemid 43118146)
26. Day DL, Shapiro RS, Yueh N, McClain K, Allan BT, Filipovich AH. B-cell lymphoproliferative disorders in children after bone marrow transplantation: radiologic manifestations. Radiology 1987;162(3):807-810. (Pubitemid 17019217)
27. Lones MA, Lopez-Terrada D, Shintaku IP, Rosenthal J, Said JW. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization. Arch Pathol Lab Med 1998;122(8):708-714. (Pubitemid 28364138)
28. Lassau N, Leclère J, Auperin A, et al. Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients. Radiology 1997;204(2):545-552. (Pubitemid 27337510)
29. Billingham RE. The biology of graft-versus-host reactions. Harvey Lect 1966-1967;62:21-78.
30. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009;373(9674):1550-1561.
31. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005;11(12):945-956.
32. Baron F, Storb R. Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review. Springer Semin Immunopathol 2004;26(1-2):71-94. (Pubitemid 40021958)
33. Martin PJ, McDonald GB, Sanders JE, et al. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2004;10(5):320-327. (Pubitemid 38519570)
34. Atkinson K, Horowitz MM, Gale RP, et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990;75(12):2459-2464. (Pubitemid 20202328)
35. Ochs LA, Miller WJ, Filipovich AH, et al. Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation. Bone Marrow Transplant 1994;13(4):455-460. (Pubitemid 24116748)
36. Akpek G, Chinratanalab W, Lee LA, et al. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol Blood Marrow Transplant 2003;9(1):46-51. (Pubitemid 41123053)
37. Cahn JY, Klein JP, Lee SJ, et al. Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC)-Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood 2005;106(4):1495-1500.
38. Lee SJ, Klein JP, Barrett AJ, et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002;100(2):406-414. (Pubitemid 34761100)
39. Socié G, Stone JV, Wingard JR, et al, for the Late Effects Working Committee of the International Bone Marrow Transplant Registry. Long-term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med 1999;341(1):14-21.
40. Wingard JR, Piantadosi S, Vogelsang GB, et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 1989;74(4):1428-1435. (Pubitemid 19227458)
41. Weisdorf DJ, Snover DC, Haake R, et al. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood 1990;76(3):624-629. (Pubitemid 20251834)
42. Couriel D, Caldera H, Champlin R, Komanduri K. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer 2004;101(9):1936-1946. (Pubitemid 39425368)
43. Benya EC, Sivit CJ, Quinones RR. Abdominal complications after bone marrow transplantation in children: sonographic and CT findings. AJR Am J Roentgenol 1993;161(5):1023-1027. (Pubitemid 23333165)
44. Brodoefel H, Bethge W, Vogel M, et al. Early and late-onset acute GvHD following hematopoietic cell transplantation: CT features of gastrointestinal involvement with clinical and pathological correlation. Eur J Radiol 2010;73(3):594-600.
45. Kalantari BN, Mortelé KJ, Cantisani V, et al. CT features with pathologic correlation of acute gastrointestinal graft-versus-host disease after bone marrow transplantation in adults. AJR Am J Roentgenol 2003;181(6):1621- 1625. (Pubitemid 37466542)
46. Donnelly LF, Morris CL. Acute graft-versus-host disease in children: abdominal CT findings. Radiology 1996;199(1):265-268. (Pubitemid 26095845)
47. Görg C, Wollenberg B, Beyer J, Stolte MS, Neubauer A. High-resolution ultrasonography in gastrointestinal graft-versus-host disease. Ann Hematol 2005;84(1):33-39. (Pubitemid 39618778)
48. Klein SA, Martin H, Schreiber-Dietrich D, et al. A new approach to evaluating intestinal acute graft-versus-host disease by transabdominal sonography and colour Doppler imaging. Br J Haematol 2001;115(4):929-934. (Pubitemid 34042912)
49. Belli AM, Williams MP. Graft versus host disease: findings on plain abdominal radiography. Clin Radiol 1988;39(3):262-264.
50. Horton KM, Corl FM, Fishman EK. CT evaluation of the colon: inflammatory disease. RadioGraphics 2000;20(2):399-418.
51. Katz JA, Wagner ML, Gresik MV, Mahoney DH Jr, Fernbach DJ. Typhlitis: an 18-year experience and postmortem review. Cancer 1990;65(4):1041-1047. (Pubitemid 20063513)
52. Jones B, Fishman EK, Kramer SS, et al. Computed tomography of gastrointestinal inflammation after bone marrow transplantation. AJR Am J Roentgenol 1986;146(4):691-695. (Pubitemid 16117257)
53. Beschorner WE. Destruction of the intestinal mucosa after bone marrow transplantation and graft-versus-host disease. Surv Synth Pathol Res 1984;3(3):264-274.
54. Wall SD, Jones B. Gastrointestinal tract in the immunocompromised host: opportunistic infections and other complications. Radiology 1992;185(2):327-335.
55. Cocozzella D, Méndez C, Malacalza J, et al. Liver dysfunction in recipients of hematopoietic stem cells: impact on mortality [in Spanish]. Medicina (B Aires) 2005;65(2):113-116. (Pubitemid 40744348)
56. Richardson P, Guinan E. The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches. Br J Haematol 1999;107(3):485-493.
57. Martin PJ, Schoch G, Fisher L, et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990;76(8):1464-1472. (Pubitemid 20364008)
58. Strasser SI, Shulman HM, Flowers ME, et al. Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis. Hepatology 2000;32(6):1265-1271.
59. Ketelsen D, Vogel W, Bethge W, et al. Enlargement of the common bile duct in patients with acute graft-versus-host disease: what does it mean? AJR Am J Roentgenol 2009;193(3):W181-W185.
60. Wiboltt KS, Jeffrey RB Jr. Acalculous cholecystitis in patients undergoing bone marrow transplantation. Eur J Surg 1997;163(7):519-524. (Pubitemid 27304678)
61. Erturk SM, Mortelé KJ, Binkert CA, et al. CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation. AJR Am J Roentgenol 2006;186(6):1497-1501. (Pubitemid 46112510)
62. Ramasamy K, Lim ZY, Pagliuca A, et al. Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoi etic stem cell transplantation (HSCT). Bone Marrow Transplant 2006;38(12):823-824. (Pubitemid 44830843)
63. Richardson P, Guinan E. Hepatic veno-occlusive disease following hematopoietic stem cell transplantation. Acta Haematol 2001;106(1-2):57-68. (Pubitemid 32830517)
64. Haire WD. Multiple organ dysfunction syndrome in hematopoietic stem cell transplantation. Crit Care Med 2002;30(5 suppl):S257-S262. (Pubitemid 34508000)
65. Senzolo M, Germani G, Cholongitas E, Burra P, Burroughs AK. Veno occlusive disease: update on clinical management. World J Gastroenterol 2007;13(29):3918-3924. (Pubitemid 47272486)
66. Yoshimoto K, Ono N, Okamura T, Sata M. Recent progress in the diagnosis and therapy for veno-occlusive disease of the liver. Leuk Lymphoma 2003;44(2):229-234. (Pubitemid 36113856)
67. Haussmann U, Fischer J, Eber S, Scherer F, Seger R, Gungor T. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy. Haematologica 2006;91(6):795-800.
68. Peres E, Kintzel P, Dansey R, et al. Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease. Blood Coagul Fibrinolysis 2008;19(3):203-207. (Pubitemid 351498723)
69. Brown BP, Abu-Yousef M, Farner R, LaBrecque D, Gingrich R. Doppler sonography: a non-invasive method for evaluation of hepatic venocclusive disease. AJR Am J Roentgenol 1990;154(4):721-724. (Pubitemid 20114584)
70. Herbetko J, Grigg AP, Buckley AR, Phillips GL. Venoocclusive liver disease after bone marrow transplantation: findings at duplex sonography. AJR Am J Roentgenol 1992;158(5):1001-1005.
71. Hommeyer SC, Teefey SA, Jacobson AF, et al. Venocclusive disease of the liver: prospective study of US evaluation. Radiology 1992;184(3):683-686.
72. Teefey SA, Brink JA, Borson RA, Middleton WD. Diagnosis of venoocclusive disease of the liver after bone marrow transplantation: value of duplex sonography. AJR Am J Roentgenol 1995;164(6):1397-1401.
73. McCarville MB, Hoffer FA, Howard SC, Goloubeva O, Kauffman WM. Hepatic venoocclusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings. Pediatr Radiol 2001;31:102-105. (Pubitemid 32124467)
74. Sharma P, McDonald GB, Banaji M. The risk of bleeding after percutaneous liver biopsy: relation to platelet count. J Clin Gastroenterol 1982;4(5):451-453. (Pubitemid 12027107)
75. Esposito AA, Nicolini A, Meregaglia D, Sangiovanni A, Biondetti P. Role of transjugular liver biopsy in the diagnostic and therapeutic management of patients with severe liver disease. Radiol Med (Torino) 2008;113(7):1008-1017.
76. Habdank K, Restrepo R, Ng V, et al. Combined sonographic and fluoroscopic guidance during transjugular hepatic biopsies performed in children: a retrospective study of 74 biopsies. AJR Am J Roentgenol 2003;180(5):1393-1398. (Pubitemid 36504633)
77. Hoffer FA. Liver biopsy methods for pediatric oncology patients. Pediatr Radiol 2000;30(7):481-488. (Pubitemid 30438679)
78. Zenz T, Rössle M, Bertz H, Siegerstetter V, Ochs A, Finke J. Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation: role of transjugular intrahepatic portosystemic shunt (TIPS). Liver 2001;21(1):31-36. (Pubitemid 32112017)
79. Carreras E, Grañena A, Navasa M, et al. Transjugular liver biopsy in BMT. Bone Marrow Transplant 1993;11(1):21-26. (Pubitemid 23086842)
80. Carreras E, Grañena A, Navasa M, et al. On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease. Ann Hematol 1993;66(2):77-80. (Pubitemid 23079672)
81. Shulman HM, Gooley T, Dudley MD, et al. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995;59(7):1015-1022.
82. Rogler G, Meinel A, Lingauer A, et al. Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease. Eur J Clin Invest 1999;29(4):330-336. (Pubitemid 29188826)
83. Schottelius A, Wedel S, Weltrich R, et al. Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease. Am J Gastroenterol 2000;95(8):1994-1999.
84. Arai S, Margolis J, Zahurak M, Anders V, Vogelsang GB. Poor outcome in steroidrefractory graft-versus-host disease with antithymocyte globulin treatment. Biol Blood Marrow Transplant 2002;8(3):155-160. (Pubitemid 34285074)
85. Marty FM, Lee SJ, Fahey MM, et al. Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. Blood 2003;102(8):2768-2776. (Pubitemid 37258330)
86. Przepiorka D, Kernan NA, Ippoliti C, et al. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood 2000;95(1):83-89. (Pubitemid 30017229)
87. Billaud EM. Clinical pharmacology of immunosuppressive drugs: year 2000 - time for alternatives. Therapie 2000;55(1):177-183.
88. Brandenburg U, Gottlieb D, Bradstock K. Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Leuk Lymphoma 1998;31(5-6):545-550. (Pubitemid 29050595)
89. Bloom AI, Shapira MY, Or R, et al. Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trial. Clin Ther 2004;26(3):407-414. (Pubitemid 38457333)
90. Nakai K, Tajima K, Tanigawa N, et al. Intraarterial steroid-injection therapy for steroid-refractory acute graft-versus-host disease with the evaluation of angiography. Bone Marrow Transplant 2004;33(12):1231-1233. (Pubitemid 38961482)
91. Sato T, Sakamaki S, Nagaoka Y, et al. Intramesenteric artery steroid administration relieved severe refractory gastro-intestinal graft-vs-host disease in an allogeneic bone marrow transplantation patient. Am J Hematol 1997;56(4):277-280. (Pubitemid 127471682)
92. Shapira MY, Bloom AI, Or R, et al. Intraarterial catheter directed therapy for severe graft-versus-host disease. Br J Haematol 2002;119(3):760-764. (Pubitemid 35366219)
93. Tfayli A, Selby G, Maqbool F, Bierbaum W, Hamadani M. Role of intra-arterial steroid administration in the management of steroid-refractory acute gastrointestinal graft-versushost disease. Am J Hematol 2006;81(12):959-962. (Pubitemid 44864455)
94. Weintraub JL, Belanger AR, Sung CC, Stangl PA, Nowakowski FS, Lookstein RL. Intra-arterial methylprednisolone infusion in treatment-resistant graft-versus-host disease. Cardiovasc Intervent Radiol 2010;33(3):509-512.
95. Azoulay D, Castaing D, Lemoine A, Hargreaves GM, Bismuth H. Transjugular intrahepatic portosystemic shunt (TIPS) for severe venoocclusive disease of the liver fol lowing bone marrow transplantation. Bone Marrow Transplant 2000;25(9):987-992. (Pubitemid 30255733)
96. Fried MW, Connaghan DG, Sharma S, et al. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. Hepatology 1996;24(3):588-591. (Pubitemid 26296002)
97. Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald GB. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993;11(9):1729-1736. (Pubitemid 23277325)
98. Boyer TD, Haskal ZJ;American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005;41(2):386-400.